Literature DB >> 10620348

Stimulation of gap junctional communication: comparison of acyclo-retinoic acid and lycopene.

W Stahl1, J von Laar, H D Martin, T Emmerich, H Sies.   

Abstract

Carotenoids and retinoids stimulate gap junctional communication (GJC), thought to be related to cancer-preventive properties. Lycopene, a nonprovitamin A carotenoid and its possible oxidation product, acyclo-retinoic acid, were tested for their effect on GJC, on stabilization of connexin43 mRNA, and on the transactivation of the RAR-beta2-promoter in vitro. In human fetal skin fibroblasts, GJC was stimulated by lycopene and acyclo-retinoic acid. Lycopene was effective at a concentration of 0.1 microM, whereas higher amounts of acyclo-retinoic acid (1 microM) were needed for comparable stimulation. Stabilizing effects of acyclo-retinoic acid on the mRNA of connexin43 via elements located in the 3'-UTR were weak. In comparison to retinoic acid (0.1 microM), considerably higher concentrations of the acyclo analog (50 microM) were required for similar effects; lycopene (0.1 microM) was not active in this system. Likewise, unphysiologically high levels of acyclo-retinoic acid (50 microM) were necessary to transactivate the RAR-beta2 promoter. The data demonstrate that acyclo-retinoic acid is much less active than retinoic acid with respect to GJC and retinoid-related signaling. Therefore, we conclude that lycopene affects GJC independent of the formation of acyclo-retinoic acid. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10620348     DOI: 10.1006/abbi.1999.1510

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  17 in total

Review 1.  Minireview: regulation of gap junction dynamics by nuclear hormone receptors and their ligands.

Authors:  Gary L Firestone; Bhumika J Kapadia
Journal:  Mol Endocrinol       Date:  2012-08-30

Review 2.  Lycopene metabolism and its biological significance.

Authors:  Xiang-Dong Wang
Journal:  Am J Clin Nutr       Date:  2012-10-10       Impact factor: 7.045

Review 3.  Nutrition and skin.

Authors:  Apostolos Pappas; Aikaterini Liakou; Christos C Zouboulis
Journal:  Rev Endocr Metab Disord       Date:  2016-09       Impact factor: 6.514

4.  Animal models in carotenoids research and lung cancer prevention.

Authors:  Jina Kim; Yuri Kim
Journal:  Transl Oncol       Date:  2011-10-01       Impact factor: 4.243

5.  Formation of cleavage products by autoxidation of lycopene.

Authors:  S J Kim; E Nara; H Kobayashi; J Terao; A Nagao
Journal:  Lipids       Date:  2001-02       Impact factor: 1.880

6.  Synthesis of apo-13- and apo-15-lycopenoids, cleavage products of lycopene that are retinoic acid antagonists.

Authors:  Sureshbabu Narayanasamy; Jian Sun; Ryan E Pavlovicz; Abdulkerim Eroglu; Cassandra E Rush; Benjamin D Sunkel; Chenglong Li; Earl H Harrison; Robert W Curley
Journal:  J Lipid Res       Date:  2017-03-01       Impact factor: 5.922

Review 7.  Tomato-based food products for prostate cancer prevention: what have we learned?

Authors:  Hsueh-Li Tan; Jennifer M Thomas-Ahner; Elizabeth M Grainger; Lei Wan; David M Francis; Steven J Schwartz; John W Erdman; Steven K Clinton
Journal:  Cancer Metastasis Rev       Date:  2010-09       Impact factor: 9.264

8.  Substrate Specificity of Purified Recombinant Chicken β-Carotene 9',10'-Oxygenase (BCO2).

Authors:  Carlo Dela Seña; Jian Sun; Sureshbabu Narayanasamy; Kenneth M Riedl; Yan Yuan; Robert W Curley; Steven J Schwartz; Earl H Harrison
Journal:  J Biol Chem       Date:  2016-05-03       Impact factor: 5.157

Review 9.  Biological activity of lycopene metabolites: implications for cancer prevention.

Authors:  Jonathan R Mein; Fuzhi Lian; Xiang-Dong Wang
Journal:  Nutr Rev       Date:  2008-12       Impact factor: 7.110

Review 10.  Carotenoid metabolism in mammals, including man: formation, occurrence, and function of apocarotenoids.

Authors:  Abdulkerim Eroglu; Earl H Harrison
Journal:  J Lipid Res       Date:  2013-05-10       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.